The Promise and Predicament of Cosmetic Neurology

Overview

Journal J Med Ethics

Publisher BMJ Publishing Group

Specialty Medical Ethics

Date 2006 Feb 1

PMID 16446417

Citations 10

Authors

A Chatterjee

Affiliations

Soon will be listed here.

Citing Articles

Overtreatment: Is a solution possible?.

Hubbeling D J Eval Clin Pract. 2021; 28(5):821-827.

PMID: 34693594 PMC: 9786860. DOI: 10.1111/jep.13632.

tDCS for Memory Enhancement: Analysis of the Speculative Aspects of Ethical Issues.

Voarino N, Dubljevic V, Racine E Front Hum Neurosci. 2017; 10:678.

PMID: 28123362 PMC: 5225120. DOI: 10.3389/fnhum.2016.00678.

From recreational to functional drug use: the evolution of drugs in American higher education, 1960-2014.

Aikins R Hist Educ. 2016; 44(1):25-43.

PMID: 27499559 PMC: 4972325. DOI: 10.1080/0046760X.2014.979251.

Smart drugs and synthetic androgens for cognitive and physical enhancement: revolving doors of cosmetic neurology.

Frati P, Kyriakou C, Del Rio A, Marinelli E, Vergallo G, Zaami S Curr Neuropharmacol. 2015; 13(1):5-11.

PMID: 26074739 PMC: 4462043. DOI: 10.2174/1570159X13666141210221750.

Generating genius: how an Alzheimer's drug became considered a 'cognitive enhancer' for healthy individuals.

Wade L, Forlini C, Racine E BMC Med Ethics. 2014; 15:37.

PMID: 24885270 PMC: 4063424. DOI: 10.1186/1472-6939-15-37.

References

Grade C, Redford B, Chrostowski J, Toussaint L, Blackwell B . Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil. 1998; 79(9):1047-50. DOI: 10.1016/s0003-9993(98)90169-1. View

Knutson B, Wolkowitz O, Cole S, Chan T, Moore E, Johnson R . Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry. 1998; 155(3):373-9. DOI: 10.1176/ajp.155.3.373. View

Shoturma D, Musaro A, Rosenthal N, Sweeney H . Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci U S A. 1998; 95(26):15603-7. PMC: 28090. DOI: 10.1073/pnas.95.26.15603. View

Russo M, Maher C, Campbell W . Cosmetic neurology: the controversy over enhancing movement, mentation, and mood. Neurology. 2005; 64(7):1320. DOI: 10.1212/wnl.64.7.1320-a. View

Kosfeld M, Heinrichs M, Zak P, Fischbacher U, Fehr E . Oxytocin increases trust in humans. Nature. 2005; 435(7042):673-6. DOI: 10.1038/nature03701. View

Kessler R, Chiu W, Demler O, Merikangas K, Walters E . Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6):617-27. PMC: 2847357. DOI: 10.1001/archpsyc.62.6.617. View

Avenanti A, Bueti D, Galati G, Aglioti S . Transcranial magnetic stimulation highlights the sensorimotor side of empathy for pain. Nat Neurosci. 2005; 8(7):955-60. DOI: 10.1038/nn1481. View

Caldwell Jr J, Caldwell J, Smythe 3rd N, Hall K . A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study. Psychopharmacology (Berl). 2000; 150(3):272-82. DOI: 10.1007/s002130000450. View

Babcock Q, Byrne T . Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health. 2000; 49(3):143-5. DOI: 10.1080/07448480009596296. View

10.

Pitman R, Sanders K, Zusman R, Healy A, Cheema F, Lasko N . Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry. 2002; 51(2):189-92. DOI: 10.1016/s0006-3223(01)01279-3. View

11.

Tse W, Bond A . Serotonergic intervention affects both social dominance and affiliative behaviour. Psychopharmacology (Berl). 2002; 161(3):324-30. DOI: 10.1007/s00213-002-1049-7. View

12.

Yesavage J, Mumenthaler M, Taylor J, Friedman L, OHara R, Sheikh J . Donepezil and flight simulator performance: effects on retention of complex skills. Neurology. 2002; 59(1):123-5. DOI: 10.1212/wnl.59.1.123. View

13.

Scott R, Bourtchuladze R, Gossweiler S, Dubnau J, Tully T . CREB and the discovery of cognitive enhancers. J Mol Neurosci. 2002; 19(1-2):171-7. DOI: 10.1007/s12031-002-0029-z. View

14.

Farah M . Emerging ethical issues in neuroscience. Nat Neurosci. 2002; 5(11):1123-9. DOI: 10.1038/nn1102-1123. View

15.

Lynch G . Memory enhancement: the search for mechanism-based drugs. Nat Neurosci. 2002; 5 Suppl:1035-8. DOI: 10.1038/nn935. View

16.

Wolpe P . Treatment, enhancement, and the ethics of neurotherapeutics. Brain Cogn. 2002; 50(3):387-95. DOI: 10.1016/s0278-2626(02)00534-1. View

17.

Turner D, Robbins T, Clark L, Aron A, Dowson J, Sahakian B . Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl). 2002; 165(3):260-9. DOI: 10.1007/s00213-002-1250-8. View

18.

Walker D, Toufexis D, Davis M . Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol. 2003; 463(1-3):199-216. DOI: 10.1016/s0014-2999(03)01282-2. View

19.

Gaudard A, Varlet-Marie E, Bressolle F, Audran M . Drugs for increasing oxygen and their potential use in doping: a review. Sports Med. 2003; 33(3):187-212. DOI: 10.2165/00007256-200333030-00003. View

20.

Tully T, Bourtchouladze R, Scott R, Tallman J . Targeting the CREB pathway for memory enhancers. Nat Rev Drug Discov. 2003; 2(4):267-77. DOI: 10.1038/nrd1061. View